Arcus Biosciences (RCUS) Cash from Operations Growth (5y) (2022 - 2026)
Arcus Biosciences (RCUS) Cash from Operations Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.58 Bn | 2.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.78% |
| Dec 31, 2025 | -19.11% |
| Sep 30, 2025 | -19.61% |
| Jun 30, 2025 | -40.91% |
| Mar 31, 2025 | -33.37% |
| Dec 31, 2024 | -60.22% |
| Sep 30, 2024 | 24.15% |
| Jun 30, 2024 | -36.62% |
| Mar 31, 2024 | 34.70% |
| Dec 31, 2023 | -65.41% |
| Sep 30, 2023 | -39.88% |
| Jun 30, 2023 | -39.27% |
| Mar 31, 2023 | -49.22% |
| Dec 31, 2022 | -45.37% |
| Sep 30, 2022 | -27.30% |
| Jun 30, 2022 | -57.00% |
| Mar 31, 2022 | 133.99% |